Zhiwei Zhang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

End Stage Renal Disease

Top Venues

Journal of clinical medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiwei Zhang, Qing Zhu
WD Repeat and HMG Box DNA Binding Protein 1: An Oncoprotein at the Hub of Tumorigenesis and a Novel Therapeutic Target. International journal of molecular sciences 24 (15) (2023)
Zhiwei Zhang, Qunli Xiong, Yongfeng Xu, Xuebin Cai, Lisha Zhang, Qing Zhu
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of clinical medicine 12 (4) (2023)
Zhiwei Zhang, Qunli Xiong, Yongfeng Xu, Xuebin Cai, Lisha Zhang, Qing Zhu
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of clinical medicine 12 (4) (2023)
Zhiwei Zhang, Qunli Xiong, Yongfeng Xu, Xuebin Cai, Lisha Zhang, Qing Zhu
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of clinical medicine 12 (4) (2023)
Zhiwei Zhang, Qunli Xiong, Yongfeng Xu, Xuebin Cai, Lisha Zhang, Qing Zhu
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of clinical medicine 12 (4) (2023)